Evidence map›Paper›PMID 17254963›Full record

ReviewCell2007

Another piece of the p27Kip1 puzzle.

Philipp Kaldis

Open access · bronzeAbstract readCommentReview
PubMed Publisher
In one paragraph

Review in Cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. P27 Protects Cardiomyocytes from Sepsis via Activation of Autophagy and Inhibition of Apoptosis.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  9. Article
  10. Angiotensin II signalling kicks out p27The Journal of physiology · 2017
    Article
  11. Cyclin A2 regulates erythrocyte morphology and numbers.Cell cycle (Georgetown, Tex.) · 2016
    Article
  12. The Speedy A, Cdk2, p27 triangle.Cell cycle (Georgetown, Tex.) · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Philipp KaldisMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Building 560/22-56, 1050 Boyles Street, Frederick, MD 21702, USA. kaldis@ncifcrf.gov
Frederick National Laboratory for Cancer Research · US

Funding

Regulation of the cell cycle by cyclin-dependent kinasesZ01SC010367 · SC · CLINICAL SCIENCES · PI KALDIS, PHILIPP · 2001 to 2007
$1.2M
Intramural NIH HHS
6 · The paper itself

Abstract

How extracellular signals communicate with the cell cycle is poorly understood. In this issue, two papers address this problem by reporting phosphorylation of the cyclin-dependent kinase inhibitor p27Kip1 on a tyrosine residue by nonreceptor tyrosine kinases, which decreases p27 stability. This new mechanism could explain how cells enter the cell cycle from a quiescent state.

Indexed as

AnimalsCell CycleCell Cycle ProteinsCell Transformation, NeoplasticCyclin-Dependent Kinase Inhibitor p27Extracellular SpaceHumansPhosphorylationProtein-Tyrosine KinasesSignal TransductionTyrosineCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27Protein-Tyrosine KinasesTyrosine

Identifiers

PMID17254963
OpenAlexW2032456072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.